PM

Peter Mark Menezes

Active Director Additional Director DIN 11330797
DIN 11330797 First appointment Dec 2025 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value •••• Premium profile

About Peter Mark Menezes

Data last updated:

Peter Mark Menezes is an Additional Director at Menezes Pharmaceuticals Limited (since 2025). The company operates in Financial Services. Menezes Pharmaceuticals Limited reported revenue of ₹17.15 Cr (FY 2025).

DIN 11330797
Primary Designation Additional Director
Industry Financial Services
First Appointment 18 Dec 2025
Largest company Menezes Pharmaceuticals Limited · ₹17.15 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Menezes Pharmaceuticals Limited U24232GA1996PLC002040
Additional Director18 Dec 2025₹17.15 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Menezes Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Peter Mark Menezes

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peter Mark Menezes

Peter Mark Menezes currently holds 1 directorship: Menezes Pharmaceuticals Limited (Additional Director, since 18 Dec 2025, revenue ₹17.15 Cr (FY 2025)).

Peter Mark Menezes was first appointed on 18 Dec 2025 as Additional Director at Menezes Pharmaceuticals Limited.

The current boards of Peter Mark Menezes's companies include Brenda Juliette Nazareth Menezes (Menezes Pharmaceuticals Limited), Christine Stephanie Menezes (Menezes Pharmaceuticals Limited), Maryann Veronica Menezes (Menezes Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available